Tuberculous pericarditis with and without HIV

Heart Failure Reviews

Volumn 18, Issue 3, 2013, Pages 367-373

  Ntsekhe, Mpiko ^a   Mayosi, Bongani M ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Human immunodeficiency virus; Tuberculous pericarditis

Indexed keywords

ADENOSINE DEAMINASE; ANTIRETROVIRUS AGENT; CORTICOSTEROID; ISONIAZID; RIFAMPICIN;

ARTICLE; CD4+ T LYMPHOCYTE; CONSTRICTIVE PERICARDITIS; EXTRAPULMONARY TUBERCULOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; MIXED INFECTION; MORTALITY; PANDEMIC; PATHOGENESIS; PERICARDIAL EFFUSION; ST SEGMENT; THORAX RADIOGRAPHY; TUBERCULOUS PERICARDITIS; UNSPECIFIED SIDE EFFECT;

CARDIAC IMAGING TECHNIQUES; COINFECTION; DISEASE MANAGEMENT; HEMODYNAMICS; HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MICROBIAL INTERACTIONS; MYCOBACTERIUM TUBERCULOSIS; PERICARDITIS, TUBERCULOUS; PERICARDIUM; SEVERITY OF ILLNESS INDEX;

EID: 84877797884     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-012-9310-6     Document Type: Article

References (54)

1. Reuter H, Burgess LJ, Doubell AF (2005) Epidemiology of pericardial effusions at a large academic hospital in South Africa. Epidemiol Infect 133(3):393-399
2. Mayosi BM, Burgess LJ, Doubell AF (2005) Tuberculous pericarditis. Circulation 112(23):3608-3616
3. Imazio M, Brucato A, Maestroni S, Cumetti D, Belli R, Trinchero R, Adler Y (2011) Risk of constrictive pericarditis after acute pericarditis. Circulation 124(11):1270-1275
4. Fowler NO (1991) Tuberculous pericarditis. JAMA 266:99-103
5. Lucas SB, Hounnou A, Peacock C, Beaumel A, Djomand G, N'Gbichi JM, Yeboue K, Honde M, Diomande M, Giordano C et al (1993) The mortality and pathology of HIV infection in a west African city. AIDS 7(12):1569-1579
6. Rana F, Hawken MP, Meme HK, Chakaya JM, Githui WA, Odhiambo JA, Porter JD, McAdam KP, Lucas SJ (1997) Autopsy findings in HIV-1-infected adults in Kenya. J Acquir Immune Defic Syndr Hum Retrovirol 14(1):83-85
7. Ntsekhe M, Hakim J (2005) Impact of human immunodeficiency virus infection on cardiovascular disease in Africa. Circulation 112(23):3602-3607
8. Maher D, Harries AD (1997) Tuberculous pericardial effusion: a prospective clinical study in a low-resource setting-Blantyre, Malawi. Int J Tuberc Lung Dis 1(4):358-364
9. Cegielski JP, Lwakatare J, Dukes CS, Lema LE, Lallinger GJ, Kitinya J, Reller LB, Sheriff F (1994) Tuberculous pericarditis in Tanzanian patients with and without HIV infection. Tuber Lung Dis 75(6):429-434
10. Cegielski JP, Ramiya K, Lallinger GJ, Mtulia IA, Mbaga IM (1990) Pericardial disease and human immunodeficiency virus in Dar es Salaam, Tanzania. Lancet 335(8683):209-212
11. Lawn SD, Zumla AI (2011) Tuberculosis. Lancet 378(9785):57-72
12. Maartens G, Wilkinson RJ (2007) Tuberculosis. Lancet 370(9604):2030-2043
13. Heimann HL, Binder S (1940) Tuberculous pericarditis. Br Heart J 2(3):165-176
14. Peel AA (1948) Tuberculous pericarditis. Br Heart J 10(3):195-207
15. Syed FF, Mayosi BM (2007) A modern approach to tuberculous pericarditis. Prog Cardiovasc Dis 50(3):218-236
16. Commerford PJ, Strang JIG (1991) Tuberculous pericarditis. In: Coovadia HM, Benatar SR (eds) A century of tuberculosis. South African perspectives, vol 1, 1st edn. Oxford University Press, Capetown, pp 123-137
17. Schutz C, Meintjes G, Almajid F, Wilkinson RJ, Pozniak A (2010) Clinical management of tuberculosis and HIV-1 co-infection. Eur Respir J 36(6):1460-1481
18. Maisch B, Maisch S, Kochsiek K (1982) Immune reactions in tuberculous and chronic constrictive pericarditis. Clinical data and diagnostic significance of antimyocardial antibodies. Am J Cardiol 50(5):1007-1013
19. Dannenberg AM Jr (1991) Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol Today 12(7):228-233
20. Reuter H, Burgess LJ, Carstens ME, Doubell AF (2006) Characterization of the immunological features of tuberculous pericardial effusions in HIV positive and HIV negative patients in contrast with non-tuberculous effusions. Tuberculosis (Edinb) 86(2):125-133
21. Reuter H, Burgess LJ, Schneider J, Van Vuuren W, Doubell AF (2006) The role of histopathology in establishing the diagnosis of tuberculous pericardial effusions in the presence of HIV. Histopathology 48(3):295-302
22. Matthews K, Ntsekhe M, Syed F, Scriba T, Russell J, Tibazarwa K, Deffur A, Hanekom W, Mayosi BM, Wilkinson RJ, Wilkinson KA (2012) HIV-1 infection alters CD4+ memory T-cell phenotype at the site of disease in extrapulmonary tuberculosis. Eur J Immunol 42(1):147-157
23. Kreinin S (1960) Tuberculous pericarditis observed from the stage of effusion to pericardial calcification. Am Rev Respir Dis 81:585-587
24. Pozniak AL, Weinberg J, Mahari M, Neill P, Houston S, Latif A (1994) Tuberculous pericardial effusion associated with HIV infection: a sign of disseminated disease. Tuber Lung Dis 75(4):297-300
25. Shafer RW, Kim DS, Weiss JP, Quale JM (1991) Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore) 70(6):384-397
26. Myers RB, Spodick DH (1999) Constrictive pericarditis: clinical and pathophysiologic characteristics. Am Heart J 138(2 Pt 1):219-232
27. Little WC, Freeman GL (2006) Pericardial disease. Circulation 113(12):1622-1632
28. Ntsekhe M, Wiysonge CS, Gumedze F, Maartens G, Commerford PJ, Volmink JA, Mayosi BM (2008) HIV infection is associated with a lower incidence of constriction in presumed tuberculous pericarditis: a prospective observational study. PLoS ONE 3(6):e2253
29. Strang JI (1984) Tuberculous pericarditis in Transkei. Clin Cardiol 7:667-670
30. Hancock EW (1971) Subacute effusive-constrictive pericarditis. Circulation 43(2):183-192
31. Mayosi BM, Wiysonge CS, Ntsekhe M, Volmink JA, Gumedze F, Maartens G, Aje A, Thomas BM, Thomas KM, Awotedu AA, Thembela B, Mntla P, Maritz F, Ngu Blackett K, Nkouonlack DC, Burch VC, Rebe K, Parish A, Sliwa K, Vezi BZ, Alam N, Brown BG, Gould T, Visser T, Shey MS, Magula NP, Commerford PJ (2006) Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis 6:2
32. Hancock EW (2004) A clearer view of effusive-constrictive pericarditis. N Engl J Med 350(5):435-437
33. Evans W, Jackson F (1952) Constrictive pericarditis. Br Heart J 14(1):53-59
34. Cinar B, Enc Y, Goksel O, Cimen S, Ketenci B, Teskin O, Kutlu H, Eren E (2006) Chronic constrictive tuberculous pericarditis: risk factors and outcome of pericardiectomy. Int J Tuberc Lung Dis 10(6):701-706
35. Mayosi BM, Wiysonge CS, Ntsekhe M, Gumedze F, Volmink JA, Maartens G, Aje A, Thomas BM, Thomas KM, Awotedu AA, Thembela B, Mntla P, Maritz F, Blackett KN, Nkouonlack DC, Burch VC, Rebe K, Parrish A, Sliwa K, Vezi BZ, Alam N, Brown BG, Gould T, Visser T, Magula NP, Commerford PJ (2008) Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. S Afr Med J 98(1):36-40
36. Niakara A, Kambire Y, Drabo YJ (2001) Pericarditis in HIV infected patients: retrospective study of 40 cases in Ouagadougou, Burkina Faso. Sante 11(3):167-172
37. Teraoka K, Hirano M, Yannbe M, Ohtaki Y, Ohkubo T, Abe K, Yamashina A (2005) Delayed contrast enhancement in a patient with perimyocarditis on contrast-enhanced cardiac MRI: case report. Int J Cardiovasc Imaging 21(2-3):325-329
38. Roubille F, Gahide G, Granier M, Cornillet L, Vernhet-Kovacsik H, Moore-Morris T, Macia JC, Piot C (2008) Likely tuberculous myocarditis mimicking an acute coronary syndrome. Intern Med 47(19):1699-1701
39. Merx MW, Weber C (2007) Sepsis and the heart. Circulation 116(7):793-802
40. Ntsekhe M, Mayosi BM (2009) Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med 6(2):120-127
41. Lawn SD, Harries AD (2011) Reducing tuberculosis-associated early mortality in antiretroviral treatment programmes in sub-Saharan Africa. AIDS 25(12):1554-1555; author reply 1556
42. Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH (2004) Guidelines on the diagnosis and management of pericardial diseases executive summary; the task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 25(7):587-610
43. Reuter H, Burgess L, van Vuuren W, Doubell A (2006) Diagnosing tuberculous pericarditis. QJM 99(1460-2725 (Print) VI-99 IP-12 DP-2006 Dec):827-39
44. Strang JI, Kakaza HH, Gibson DG, Allen BW, Mitchison DA, Evans DJ, Girling DJ, Nunn AJ, Fox W (1988) Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei. Lancet 2(8614):759-766
45. Strang JI, Kakaza HH, Gibson DG, Girling DJ, Nunn AJ, Fox W (1987) Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. Lancet 2(8573):1418-1422
46. Hakim JG, Ternouth I, Mushangi E, Siziya S, Robertson V, Malin A (2000) Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients. Heart 84(2):183-188. doi: 10.1136/heart.84.2.183
47. Reuter H, Burgess LJ, Louw VJ, Doubell AF (2007) The management of tuberculous pericardial effusion: experience in 233 consecutive patients. Cardiovasc J S Afr 18(1):20-25
48. Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, Zumla A (2010) Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 375(9729):1920-1937
49. Louw A, Tikly M (2007) Purulent pericarditis due to co-infection with Streptococcus pneumoniae and Mycobacterium tuberculosis in a patient with features of advanced HIV infection. BMC Infect Dis 7:12
50. Harvey AM, Whitehill MR (1937) Tuberculous pericarditis. Medicine 16:45-94
51. Maher D, Uplekar M, Blanc L, Raviglione M (2003) Treatment of tuberculosis. BMJ 327(7419):822-823
52. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, Gengiah T, Nair G, Bamber S, Singh A, Khan M, Pienaar J, El-Sadr W, Friedland G, Abdool Karim Q (2010) Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 362(8):697-706
53. Ntsekhe M, Wiysonge C, Volmink JA, Commerford PJ, Mayosi BM (2003) Adjuvant corticosteroids for tuberculous pericarditis: promising, but not proven. QJM 96(8):593-599
54. Baciewicz AM, Chrisman CR, Finch CK, Self TH (2008) Update on rifampin and rifabutin drug interactions. Am J Med Sci 335(2):126-136